We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

QIBK:QSEQatar Islamic Bank Analysis

Data as of 2026-03-13 - not real-time

QAR 22.58

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Qatar Islamic Bank trades at QAR 22.58, delivering a trailing P/E of about 11.6, well below the regional banking average of 16.4, suggesting a valuation discount. The stock offers a dividend yield near 4% with a payout ratio under 50%, making it attractive for income‑focused investors. Technical signals are mixed: the 20‑day SMA (23.91) sits above the current price, the RSI at 35 points to modest oversold pressure, while the MACD remains bearish and the overall trend is neutral. Support around QAR 21.80 provides a floor, and the price is still 15% below the analyst mean target of 25.99, indicating upside potential. However, operating cash flow is negative and volatility over the past month exceeds 26%, which tempers enthusiasm.
Given the low beta (≈0.3) and increasing volume, liquidity risk is limited, but the concentration in a single Gulf market adds geographic exposure. The bank’s strong capital base (price‑to‑book 1.8) and solid profit margin (≈43%) support the dividend, yet the recent –5% revenue contraction raises questions about sustainable growth. In a market environment characterized by a “Greed” sentiment index of 72.7, the stock appears fairly priced on a value basis with a modest upside, making a cautious buy stance appropriate for medium horizons while a hold is prudent in the short run.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • price near support level
  • moderate oversold RSI
  • high dividend yield

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • valuation discount to peers
  • upside potential to analyst target
  • stable profit margins

Long Term

> 3 years
Neutral
Model confidence: 7/10

Key Factors

  • sustainable dividend income
  • negative operating cash flow
  • limited growth prospects

Key Metrics & Analysis

Financial Health

Revenue Growth-5.00%
Profit Margin43.29%
P/E Ratio11.6
ROE14.74%
ROA2.29%
P/B Ratio1.8
Op. Cash FlowQAR-2077851008
Industry P/E16.4

Technical Analysis

TrendNeutral
RSI35.7
SupportQAR 21.80
ResistanceQAR 25.49
MA 20QAR 23.91
MA 50QAR 24.40
MA 200QAR 23.84
MACDBearish
VolumeIncreasing
Fear & Greed Index72.66

Valuation

Target PriceQAR 25.99
Upside/Downside15.08%
GradeUndervalued
TypeValue
Dividend Yield3.99%

Risk Assessment

Beta0.26
Volatility26.22%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.